作为引领中国医药产业走向世界的“名片”，“第二十三届世界制药原料中国展（CPHI China 2025）”将携手“第十八届世界制药机械、包装设备与材料中国展”（PMEC China 2025）于6月24-26日在上海新国际博览中心高燃来袭。海翔药业将携国际化营销团队深度参与本届盛会，与全球合作伙伴共享发展机遇，憧憬医药产业崭新未来。
CPHI China 2025, a bellwether for China’s pharmaceutical industry onto the global stage, will run from June 24th to 26th , 2025,at the Shanghai New International Expo Centre together with PMEC China 2025. The international marketing team of Hisoar will participate in this grand event,sharing development opportunities and envisioning a bright future with global partners for the pharmaceutical industry.
诚邀您莅临E1K01 展位，与海翔药业开展战略对话：
1、制剂/原料药/中间体/多肽缩合剂解决方案和合作
2、定制化一站式CDMO/CMO服务
3、全球化市场合作
Welcome to Booth E1K01. Let’s make a strategic dialogue about,
1.Solutions and collaboration for formulations, APIs, intermediates, peptide coupling reagents;
2. Customized one-stop CDMO and CMO services; and
3. Global market cooperation.
让展会搭建你我沟通桥梁，我们共同携手提振产业创新，赋能医药行业健康发展。
Let’s bridge communication in this exhibition, where industry innovation is invigorated and sustainable growth is empowered.
关于海翔药业：
海翔药业业务涵盖医药、染料全产业链，医药板块业务涉及特色原料药及医药中间体、仿制药的研发和商业化生产销售，染料板块业务涉及染颜料中间体及环保型活性染料的研发、生产及销售。培南系列产品获得多项国家发明专利，是全球最大生产厂家之一；克林霉素系列国内产量和出口量领先；氟苯尼考产品在法规市场占有率领先；具备完善的GMP,EHS体系，可提供一站式CDMO/CMO定制服务；是多肽缩合剂系列产品可信赖的供应商。
About Hisoar:
Zhejiang Hisoar Pharmaceutical Co., Ltd. operates across the full-industry chains of pharmaceuticals and dye.
The pharmaceutical segment covers R D, commercial production, and sales of APIs, intermediates, and generic drugs. The dye segment involves R D, production, and sales of dye intermediates and eco-friendly reactive dyes. Hisoar has complete GMP and EHS systems and provides one-stop CDMO and CMO solutions.
Flagship products include:
- Carbapenem series with multiple national patents, of which Hisoar is a global leader in production;
- Clindamycin series, of which Hisoar is a top manufacturer and exporter in China;
- Florfenicol, of which Hisoar leads in regulated markets; and
- Peptide coupling reagents, of which Hisoar is a trusted supplier.